CoChat

Prognostic value of the systemic inflammation response index in human malignancy: A meta-analysis

Open access
Wei, Lishuang, Xie, Hailun, Yan, Ping · 2020 · Medicine

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

Background: This meta-analysis aimed to evaluate the prognostic value of the systemic inflammation response index (SIRI) in malignancy based on existing evidence. Methods: We searched for relevant literature published in the electronic databases PubMed, Web of Science, Cochrane Library, and Embase before April 10, 2020. Hazard ratios (HR) and corresponding 95% confidence intervals (CI) were calculated and pooled to evaluate the relationship between SIRI and malignancy outcomes. Results: We included 14 articles, describing 6,035 patients. Our findings revealed that patients with high SIRI had worse overall survival (OS) (HR = 2.20, 95% CI: 1.85–2.62, P < .001), disease-free survival (DFS) (HR: 1.92, 95% CI: 1.49–2.48, P < .001), time-to-progression (TTP) (HR: 2.00, 95% CI: 1.55–2.58, P < .001), progression-free survival (PFS) (HR: 1.73, 95% CI: 1.38–2.16, P < .001), cancer-specific survival (CSS) (HR: 3.57, 95% CI: 2.25–5.68, P < 0.001), disease-specific survival (DSS) (HR: 1.99, 95% CI: 1.46 - 2.72, P < .001), and metastasis-free survival (MFS) (HR: 2.26, 95% CI: 1.28–3.99, P = .005) than patients with low SIRI. The correlation between SIRI and OS did not change in a subgroup analysis. Meta-regression indicated that heterogeneity may be related to differences in primary therapy strategies. Sensitivity analysis suggested that our results were reliable. Conclusions: SIRI could be used as a useful predictor of poor prognosis during malignancy treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/md.0000000000023486

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The flow chart of the literature selection.
Figure 1 The flow chart of the literature selection.CC BY-NC · PubMed Central
Figure 2 Forest plot for the association between SIRI and OS. OS = overall survival, SIRI = systemic inflammation response index.
Figure 2 Forest plot for the association between SIRI and OS. OS = overall survival, SIRI = systemic inflammation response index.CC BY-NC · PubMed Central
Figure 3 Forest plot for the association between SIRI and other outcomes. Notes: A, forest plot for DFS; B, forest plot for TTP; C, forest plot for PFS; D, forest plot for CSS; E, forest plot for DSS; F, forest plot for MFS. CSS = cancer-specific survival, DFS = disease-free survival, DSS = disease-specific survival, MFS = metastatic-free survival, PFS = progression-free survival, SIRI = systemic inflammation response index, TTP = time-to-progression.
Figure 3 Forest plot for the association between SIRI and other outcomes. Notes: A, forest plot for DFS; B, forest plot for TTP; C, forest plot for PFS; D, forest plot for CSS; E, forest plot for DSS; F, forest plot for MFS. CSS = cancer-specific survival, DFS = disease-free survival, DSS = disease-specific survival, MFS = metastatic-free survival, PFS = progression-free survival, SIRI = systemic inflammation response index, TTP = time-to-progression.CC BY-NC · PubMed Central
Figure 4 Sensitivity analysis for the association between SIRI and OS. OS = overall survival, SIRI, systemic inflammation response index.
Figure 4 Sensitivity analysis for the association between SIRI and OS. OS = overall survival, SIRI, systemic inflammation response index.CC BY-NC · PubMed Central
Figure 5 Begg funnel plot for the assessment of potential publication bias according to OS. OS = overall survival.
Figure 5 Begg funnel plot for the assessment of potential publication bias according to OS. OS = overall survival.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 103

Metadata

Authors
Wei, L., Xie, H., & Yan, P.
Affiliations
First Affiliated Hospital of GuangXi Medical University (CN)
Corresponding author
Yan, Ping
Venue
Medicine
Published
2020-12-11
Volume
99
Issue
50
Pages
e23486
ISSN
  • 0025-7974 (ISSN-L)
  • 1536-5964
OpenAlex
W3112651280
Cited by
93
References
34
Citations by year
2026: 15 · 2025: 18 · 2024: 24 · 2023: 22 · 2022: 8 · 2021: 5
FWCI
0.94
Type
journal article
Language
en
Open access
Locations
  • Medicine (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
  • Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
Keywords
systemic inflammation response index, prognostic factors, cancer, inflammation, overall survival, disease-free survival, progression-free survival, cancer-specific survival, metastasis-free survival, treatment response
MeSH terms
Humans, Inflammation, Neoplasms, Prognosis, Biomarkers, Tumor, Disease-Free Survival

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prognostic value of the systemic inflammation response index in human malignancy: A meta-analysis. https://app.cochat.ai/papers/10.1097/md.0000000000023486
The paper
Wei, L., Xie, H., & Yan, P. (2020). Prognostic value of the systemic inflammation response index in human malignancy: A meta-analysis. Medicine. https://doi.org/10.1097/md.0000000000023486

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.